To demonstrate thoughtful portfolio management, while Johnson & Johnson and Microsoft are of the utmost high quality, they are both overvalued. Looking at my “shopping list”, I decided to split the money I received from trimming my JNJ and MSFT positions into three purchases.
With a secure yield near 4% and healthy dividend growth, this near-bulletproof dividend growth stock is a compelling idea for income-oriented investors.
The DGP wrapped up 2020 in great shape. It’s now getting back in dividends more than 10% of the original money invested… each year.
With a market-beating yield, accelerating dividend growth, and the potential that shares are 15% undervalued, dividend growth investors should consider this stock before it races higher.
With almost 20 consecutive years of dividend raises, double-digit long-term dividend growth, and the potential that shares are 21% undervalued, this looks like a great long-term opportunity for dividend growth investors.
With a market-smashing yield near 5%, double-digit dividend growth, almost a decade straight of dividend raises, and the potential that shares are 21% undervalued, this is an off-the-radar stock for dividend growth investors to strongly consider buying before it fully recovers.
With a market-beating yield, double-digit dividend growth, and the potential that shares are 15% undervalued, this stock looks like a compelling long-term opportunity for dividend growth investors.
Warren Buffett (through Berkshire Hathaway) recently started a new position in this stock — and right now it appears to be trading at a 15% discount.
This global powerhouse has a market-beating yield, double-digit long-term dividend growth, and looks potentially 8% undervalued. Now could be an opportunity to load up on this Buffett-approved stock at a discount.
With a market-beating 3%+ yield, double-digit long-term dividend growth, and the potential that shares are 26% undervalued, this is an under-the-radar stock that dividend growth investors ought to take a good look at.
